Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroepithelial cell transforming 1 pseudogene (ENSG00000236978, LOC100967223) is classified as a **pseudogene**, a genomic DNA sequence that bears strong similarity to the functional neuroepithelial cell transforming 1 (NET1) gene, but lacks the ability to produce a functional protein[1][3]. Pseudogenes are nonfunctional remnants of genes formed by duplication or retrotransposition events and frequently acquire disabling mutations rendering them incapable of gene expression or protein function[2]. While pseudogenes can sometimes play minor regulatory roles in cell biology—for example, functioning as sources of non-coding RNA or as microRNA decoys—there are no data suggesting such functions for this specific locus[4]. This pseudogene is not a validated drug or therapeutic target, nor a known biomarker for disease surveillance. The entry is considered "incorrect" if used as a therapeutic target, as it does not encode an active protein[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroepithelial cell transforming 1 pseudogene.